Keeping tabs on pharma
As the pharma industry continues to make paradigm shifts toward smart, integrated and data-rich paperless operations, discover the latest trends, best practices and industry news emerging from the pharmaceutical landscape in Pharma IQ’s bi-weekly series, Keeping tabs on pharma.
Keeping tabs on pharma: Landmark new drug approvals and Sanofi’s diversity push
April 05 by Leila Hawkins
Pharma IQ’s latest round-up has the latest drug approvals for Gilead and AstraZeneca
Keeping tabs on pharma: First precision medicine for autism spectrum disorders
March 28 by Leila Hawkins
Pharma IQ’s latest news round-up looks at the first precision medicine for autism spectrum disorders, AstraZeneca’s preventative Covid-19 shot and India’s rising cost of medication
Keeping tabs on pharma: First diabetes pill for pregnant women approved
March 07 by Leila Hawkins
Pharma IQ’s latest round-up includes a ground-breaking diabetes pill and the impact of Brexit on the medical devices market
Keeping tabs on pharma: Viagra-like drug shows promise in treating dementia
February 15 by Leila Hawkins
New research finds that a drug related to sildenafil could help treat dementia
Keeping tabs on pharma: UK hails “major step forward” in treating schizophrenia
February 08 by Leila Hawkins
UK approves first long-acting new treatment for schizophrenia, Venus Remedies joins coalition to tackle anti-microbial resistance (AMR) and FDA resumes medical device inspections as Covid rates drop
Keeping tabs on pharma: New diabetes treatment for children and DMT studied for stroke patients
February 01 by Leila Hawkins
A groundbreaking study shows great promise for children with diabetes, DMT research for stroke patients awaits approval and China tightens anti-monopoly laws
Keeping tabs on pharma: Novo Nordisk’s diabetes "game-changer" and the rise of antibiotic resistance
January 21 by Leila Hawkins
In Pharma IQ’s latest news bulletin: Novo Nordisk India’s ground-breaking diabetes pill, the threat of antibiotic resistance and a new nasal drug that could combat Covid-19
Keeping tabs on pharma: World’s first GMO heart transplant, new insomnia drug
January 14 by Leila Hawkins
In Pharma IQ’s latest news bulletin: the world’s first gene-edited pig’s heart transplant, and new drugs for insomnia and cystic fibrosis gain approval
Keeping tabs on pharma: Investors call for better vaccine access, Purdue mediation
January 07 by Leila Hawkins
Pharma IQ’s latest news update reveals demand from investors for more equitable vaccine delivery, Purdue case goes to mediation and new drugs for leukemia and peanut allergy
Keeping tabs on pharma: FDA fast tracks Novartis osteoarthritis drug and grants approval for Janssen’s long-acting schizophrenia drug
September 03 by Adam Jeffs
Pharma IQ dives into the latest updates from the FDA for new drugs that have been developed by Novartis and Janssen
Keeping tabs on pharma: Big pharma makes progress on ‘difficult-to-treat’ diseases and GHD patients receive new drug
August 31 by Adam Jeffs
Pharma IQ dives into advancements made in the field of drug discovery over the last week
Keeping tabs on Pharma: Covid-19 booster shots on the agenda and medicinal research receives investment boost
August 13 by Adam Jeffs
Covid-19 booster shots could become a necessity and investment increases for medicinal research to meet patient needs
